Jennifer Loud
#45,547
Most Influential Person Now
American nurse practitioner
Jennifer Loud's AcademicInfluence.com Rankings
Download Badge
Nursing
Why Is Jennifer Loud Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jennifer T. Loud is an American nurse practitioner who served as the assistant chief of the National Cancer Institute's clinical genetics branch until August 2020. Life Loud received a B.S. in Nursing from Old Dominion University in 1981, an M.S. in Nursing from George Mason University in 1992, and a Doctor of Nursing Practice degree from the University of Maryland, Baltimore in 2008.
Jennifer Loud's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. (2012) (544)
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk (2013) (405)
- A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population (2010) (357)
- Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohort (2016) (320)
- Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study (2010) (293)
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers (2017) (211)
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations (2018) (206)
- Meta-analysis identifies four new loci associated with testicular germ cell tumor (2013) (155)
- Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores (2017) (142)
- Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions. (2009) (139)
- Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis (2017) (139)
- Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer (2014) (135)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
- Cancer Screening and Early Detection in the 21st Century. (2017) (108)
- A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer: Design and Baseline Characteristics: A Gynecologic Oncology Group Study (2008) (104)
- Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers (2012) (92)
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
- Sisters in hereditary breast and ovarian cancer families: communal coping, social integration, and psychological well‐being (2008) (75)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
- Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. (2013) (60)
- Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants (2020) (60)
- Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
- BRCA mutation‐negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA‐negative experience (2008) (57)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
- Disclosure of Positive BRCA1/2-Mutation Status in Young Couples: The Journey From Uncertainty to Bonding Through Partner Support. (2008) (40)
- Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). (2020) (40)
- Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors (2019) (39)
- Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort (2017) (39)
- Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer (2010) (37)
- Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study (2014) (36)
- Unpacking the Blockers: Understanding Perceptions and Social Constraints of Health Communication in Hereditary Breast Ovarian Cancer (HBOC) Susceptibility Families (2011) (35)
- Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer (2008) (34)
- An anthropomorphic phantom for quantitative evaluation of breast MRI. (2011) (33)
- Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. (2019) (33)
- Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study (2012) (31)
- Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study (2014) (31)
- No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families (2010) (30)
- Mosaic chromosome Y loss and testicular germ cell tumor risk (2017) (30)
- Ductal Lavage in Women from BRCA1/2 Families: Is There a Future for Ductal Lavage in Women at Increased Genetic Risk of Breast Cancer? (2009) (29)
- Familial testicular germ cell tumors (FTGCT) – overview of a multidisciplinary etiologic study (2015) (26)
- The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers (2009) (25)
- Exploratory study of the feasibility and utility of the colored eco‐genetic relationship map (CEGRM) in women at high genetic risk of developing breast cancer (2004) (24)
- Factors associated with testicular self-examination among unaffected men from multiple-case testicular cancer families (2009) (23)
- Research participant interest in primary, secondary and incidental genomic findings (2016) (23)
- A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers (2012) (22)
- Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1/2 carriers. (2014) (22)
- Couples coping with screening burden and diagnostic uncertainty in Li-Fraumeni syndrome: Connection versus independence (2019) (21)
- Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3 (2016) (20)
- Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls (2018) (20)
- Familial testicular cancer: Interest in genetic testing among high-risk family members (2006) (20)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
- An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers (2008) (19)
- Testicular Cancer and Genetics Knowledge Among Familial Testicular Cancer Family Members (2008) (17)
- Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (2018) (17)
- Deliberate deceit of family members: a challenge to providers of clinical genetics services. (2006) (16)
- Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers (2012) (16)
- Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
- Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers (2019) (15)
- A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
- Rare inactivating PDE11A variants associated with testicular germ cell tumors. (2015) (14)
- Cancer Genetics Fundamentals (2001) (14)
- Identification of 22 susceptibility loci associated with testicular germ cell tumors (2021) (13)
- Tolerability of breast ductal lavage in women from families at high genetic risk of breast cancer (2009) (12)
- Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers (2014) (11)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (11)
- The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant (2021) (10)
- A major step forward for BRCA1/2-related cancer risk management. (2014) (9)
- Reproductive factors associated with breast cancer risk in Li-Fraumeni syndrome. (2019) (9)
- Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
- Testicular germ cell tumor susceptibility associated with the UCK 2 locus on chromosome 1 q 23 (2013) (7)
- Legacies and Relationships: Diverse Social Networks and BRCA1/2 Risk Management Decisions and Actions (2018) (7)
- Quantification of the cellular components of breast duct lavage samples (2006) (6)
- Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers (2014) (6)
- Applications of Advances in Molecular Biology and Genomics to Clinical Cancer Care (2002) (6)
- Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study® (2018) (5)
- Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort (2015) (5)
- Direct-to-Consumer Genetic and Genomic Testing: Preparing Nurse Practitioners for Genomic Healthcare. (2010) (4)
- Mammographic density does not differ between unaffectedBRCA1/2mutation carriers and women at low-to-average risk of breast cancer. (2009) (4)
- Baseline cancer screening findings from the NCI Li-Fraumeni syndrome study. (2016) (3)
- Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li–Fraumeni syndrome (2021) (2)
- Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT families (2015) (2)
- Rare inactivating PDE 11 A variants associated with testicular germ cell tumors (2015) (2)
- Inherited defects in checkpoint kinase 2 (CHEK2) to confer increased susceptibility to testicular germ cell tumors. (2018) (1)
- Abstract 2752: Genetic heterogeneity of ovarian cancer survival effects inBRCA1/2germline mutations: a large, multi-center study (2011) (1)
- Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk (2020) (1)
- Effect of breastfeeding on the risk of breast cancer in Li-Fraumeni syndrome. (2018) (1)
- Family Identity and Roles in the Context of Li-Fraumeni Syndrome: "No One's Like Us Mutants". (2021) (1)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (1)
- The art and science of cancer nursing in the genomic era. (2004) (1)
- The art and science of nursing in the genomic era (2004) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers (2012) (0)
- Abstract 3316: Screening blood tests and cancer detection in Li-Fraumeni syndrome (2019) (0)
- Tolerability of breast duct lavage in women from BRCA mutation-positive families participating in an intensive breast cancer screening trial. (2006) (0)
- Breast cancer risk in mutation-negative members of knownBRCA1/2mutation-positive families. (2009) (0)
- Association of breast cancer risk in BRCA 1 and BRCA 2 mutation carriers with genetic variants showing differential allelic expression (2016) (0)
- Preliminary results of a physical phantom for quantitative assessment of breast MRI (2009) (0)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
- CE TEST: Cancer Genetics Fundamentals (2001) (0)
- Abstract 2036: The Bull's Eye: A research tool to characterize family, friends and social networks within a Li-Fraumeni Syndrome family (2020) (0)
- Abstract 811: Mosaic chromosome Y loss is not associated with testicular germ cell tumor risk (2016) (0)
- Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls (2018) (0)
- Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
- Breast Cancer Prevention: E9 (1999) (0)
- Abstract 843: Imputation and meta-analysis of five genome-wide association studies identify multiple new loci associated with testicular germ cell tumor (2015) (0)
- Genetics of Cancer Risk (2010) (0)
- Cancer genetics resources: An organizational guide for nurses and patients (2003) (0)
- Abstract 2749: Cumulative cancer risk in the NCI Li-Fraumeni Syndrome Cohort (2015) (0)
- Abstract 5801: Rates of risk reducing mastectomy in women with Li-Fraumeni Syndrome (2020) (0)
- ' s response to reviews Title : Tolerability of Breast Ductal Lavage in Women from Families at High Genetic Risk of Breast Cancer (2009) (0)
- ' s response to reviews Title : Tolerability of Breast Ductal Lavage in Women from Families at High Genetic Risk of Breast Cancer (2009) (0)
- Abstract 3473: Psychosocial functioning in research participants at enrollment in a Li-Fraumeni syndrome study (2016) (0)
- Resource appendix: Cancer genetics resources: A guide for nurses and patients (2004) (0)
- Abstract A5: A pilot study of circulating and intrabreast tissue estrogen levels among postmenopausal BRCA1/2 mutation‐positive women (2010) (0)
- Abstract P4-06-01: Provider practice and compliance with NCCN clinical guidelines forBRCA1/2testing: Findings from Dr. Susan Love Research Foundation's The Health of Women (HOW) StudyTM (2018) (0)
This paper list is powered by the following services:
Other Resources About Jennifer Loud
What Schools Are Affiliated With Jennifer Loud?
Jennifer Loud is affiliated with the following schools:
